Skip to main content

Advertisement

SpringerLink
Log in

Highlights of melanoma research presented at the 48th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, June 1–5, 2012

  • Meeting Report
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Conflict of interest

The authors state no conflict of interest.

Author information

Authors and Affiliations

  1. The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA

    Dorothee Herlyn & Clemens Krepler

Authors
  1. Dorothee Herlyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clemens Krepler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clemens Krepler.

Glossary

AKT

Protein kinase B

APC

Antigen-presenting cell

BRAF

v-Raf murine sarcoma viral oncogene homolog B1

CDK4

Cyclin-dependent kinase 4

CDKN2A

Cyclin-dependent kinase inhibitor 2A

c-KIT

CD117, mast/stem cell growth factor receptor

CTLA-4

Cytotoxic T-lymphocyte antigen 4

DTIC

Dacarbazine

gp100

Melanocyte protein Pmel 17

HLA-A

Human leukocyte antigen-A

MART-1

Melanoma antigen recognized by T cells 1

MEK

MAP2K, mitogen-activated protein kinase kinase

MET

MNNG HOS transforming gene

mTOR

Mammalian target of Rapamycin

NRAS

Neuroblastoma RAS viral oncogene homolog

NY-ESO-1

Cancer testis antigen, New York-Esophageal Cancer-1

PD-1

Programmed cell death protein 1

PD-L1

Programmed cell death 1 ligand 1

PI3K

Phosphatidylinositide 3-kinase

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herlyn, D., Krepler, C. Highlights of melanoma research presented at the 48th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, June 1–5, 2012. Cancer Immunol Immunother 62, 1131–1135 (2013). https://doi.org/10.1007/s00262-013-1399-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-013-1399-5

Keywords

Search

Navigation